Abstract
When choosing a medication, a doctor has to be sure in its efficacy and safety for the patient. The conduct of multiple post-registration studies on different aspects of medications’ use is aimed at helping the clinician to correctly evaluate the therapeutic potential of proposed medications. The aim of present study is to evaluate the IOP-lowering efficacy and tolerability of Glauprost, Duoprost, Dorzopt Plus in POAG patients according to 24-hour IOP monitoring data by circadian rhythms measured with Icare one tonometer. The IOP monitoring by circadian rhythms allowed obtaining considerably more data for IOP-lowering efficacy evaluation in comparison with single IOP measurement using Maklakov tonometer. This increases the IOP-lowering efficacy evaluation accuracy.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call